Belgian Biotech Celyad treats patient with leukemia with alternative CAR-T threapy – Daily Sabah
|
Belgian Biotech Celyad treats patient with leukemia with alternative CAR–T threapy
Daily Sabah Celyad, a Belgium-based clinical-stage biopharmaceutical, announced Tuesday the early clinical results of a patient being treated of an aggressive type of leukemia that did not respond to chemotherapy with an alternative CAR–T cell therapy.The … |
